The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 05, 2022

Filed:

Apr. 03, 2020
Applicant:

Apellis Pharmaceuticals, Inc., Waltham, MA (US);

Inventors:

Cedric Francois, Prospect, KY (US);

Pascal Deschatelets, Lexington, MA (US);

Assignee:

Apellis Pharmaceuticals, Inc., Waltham, MA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61P 27/02 (2006.01); A61B 5/00 (2006.01); C12Q 1/37 (2006.01); A61K 49/00 (2006.01);
U.S. Cl.
CPC ...
A61B 5/4842 (2013.01); A61B 5/4848 (2013.01); A61K 49/0017 (2013.01); A61P 27/02 (2018.01); C12Q 1/37 (2013.01); G01N 2333/4716 (2013.01); G01N 2333/96433 (2013.01); G01N 2800/164 (2013.01); G01N 2800/50 (2013.01);
Abstract

In some aspects, methods of detecting complement activation in vivo, e.g., in an eye, are provided. In some embodiments, methods comprise detecting drusen containing or in close proximity to complement activation. In some embodiments methods comprise detecting one or more drusen having inflamed endothelium underlying or in close proximity thereto. In some embodiments methods comprise detecting eye-derived extracellular microvesicles, e.g., exosomes, in a body fluid. In some embodiments any of the methods further comprises treating a subject at risk of developing AMD, GA, or advanced AMD or at increased likelihood of rapid progression of AMD with a complement inhibitor. In some aspects, agents useful for performing one or more of the methods are described.


Find Patent Forward Citations

Loading…